UPDATE : Monday, September 7, 2020
상단여백
Luxturna to open gene therapies market: analyst
The latest approval by the U.S. Food and Drug Administration for Luxturna, ...
by Nam Doo-hyun  |  2018-01-10 15:48
라인
Test for fetal sex chromosome defects wins patent
A local firm has won a patent in testing fetal sex chromosome abnormalities...
by Nam Doo-hyun  |  2018-01-10 14:39
라인
Antibodies drug suggested against N. Korean anthrax threat
Amid growing concerns over biological terrorism with North Korea’s reported...
by Nam Doo-hyun  |  2018-01-05 12:03
라인
Venture capital investment in biomedical sector drops 20% in 2017
Venture capital investment in the local biomedical sector declined by 20 pe...
by Nam Doo-hyun  |  2018-01-04 09:30
라인
70% of biotech firms enjoy stock price gains in 2017
In the South Korean stock market, biopharmaceutical and pharmaceutical firm...
by Nam Doo-hyun  |  2018-01-02 17:42
라인
Kolon Life Science’s shares plummet on drifting export deal
Kolon Life Science’s shares plummeted by 15 percent on Wednesday from the p...
by Nam Doo-hyun  |  2017-12-21 13:16
라인
₩500-billion Invossa technology export to Japan in peril
Mitsubishi Tanabe Pharma notified Kolon Life Science that the Japanese drug...
by Nam Doo-hyun  |  2017-12-20 14:59
라인
Will Takeda, Dong-A ST benefit from new hypertension guideline?
As Takeda Pharmaceuticals Korea is about to release its angiotensin recepto...
by Nam Doo-hyun  |  2017-12-19 16:15
라인
Boehringer Ingelheim Korea’s labor union protests early retirement program
The labor union of Boehringer Ingelheim Korea said the company’s recent ann...
by Nam Doo-hyun  |  2017-12-19 14:35
라인
‘Celltrion’s annual revenue to top ₩3 trillion in 5 years’
Celltrion, which recently obtained Europe’s approval for breast cancer trea...
by Nam Doo-hyun  |  2017-12-18 15:55
라인
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone
Yuhan Corp.’s combination of chemotherapy with immunotherapy YH24931 has st...
by Nam Doo-hyun  |  2017-12-18 11:51
라인
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’
Over-the-counter drugs and health functional foods to alleviate symptoms of...
by Nam Doo-hyun  |  2017-12-18 10:49
라인
‘Surge of gene-therapy providing hospitals to benefit Invossa’
With hospitals increasingly registering as a provider of gene therapies, Ko...
by Nam Doo-hyun  |  2017-12-12 15:59
라인
PCL shares rise despite regulator’s warning
Shares of PCL, a provider of in vitro diagnostic products, have risen again...
by Nam Doo-hyun  |  2017-12-12 11:02
라인
Oscotec shares rebound on launch of US clinical trial
Shares of Oscotec rebounded on Monday on the company’s announcement that it...
by Nam Doo-hyun  |  2017-12-11 15:50
라인
ToolGen’s shares jump on gene therapy market expectations
With rising expectations for a rapid growth of gene therapy market, investo...
by Nam Doo-hyun  |  2017-12-11 15:16
라인
Government’s mobile healthcare pilot project proves effective
The Ministry of Health and Welfare said its pilot mobile healthcare program...
by Nam Doo-hyun  |  2017-12-07 14:37
라인
Novartis Korea faces tax investigation
The National Tax Service launched a tax investigation into Novartis Korea o...
by Nam Doo-hyun  |  2017-12-06 10:55
라인
Kolon Life Science confident to make Invossa global blockbuster
Despite proved efficacy in reducing pain for osteoarthritis patients, Kolon...
by Nam Doo-hyun  |  2017-12-06 09:30
라인
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
Most of the biotechnology companies, listed on Kosdaq early this year under...
by Nam Doo-hyun  |  2017-12-05 14:38
여백
여백
여백
Back to Top